Literature DB >> 17351161

Thromboangiitis obliterans (Buerger's disease): searching for a therapeutic strategy.

Kosmas I Paraskevas1, Christos D Liapis, Despina D Briana, Dimitri P Mikhailidis.   

Abstract

Treatment of thromboangiitis obliterans (Buerger's disease) includes both surgical and nonsurgical approaches, or a combination of both. A definite therapeutic approach has not yet been set. This article reviews the proposed therapeutic strategies and considers the advantages and disadvantages of each treatment. Cessation of smoking seems to be the only globally accepted therapeutic measure to prevent disease progression. A number of promising novel therapeutic strategies may prove useful for the treatment of this physically and socially mutilating disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17351161     DOI: 10.1177/0003319706291169

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  10 in total

1.  Treatment-of-choice for Buerger's disease (thromboangiitis obliterans): still an unresolved issue.

Authors:  Kosmas I Paraskevas
Journal:  Clin Rheumatol       Date:  2008-02-02       Impact factor: 2.980

2.  Buerger's Disease; Any Current Advances?

Authors:  Yong-Bok Koh
Journal:  Ann Vasc Dis       Date:  2008-10-24

3.  Peripheral sympathetic block with therapeutic local anesthesia for the manage-ment of upper limb digital ischemia.

Authors:  A Mahli; D Coskun; K Cosarcan
Journal:  Hippokratia       Date:  2018 Jul-Sep       Impact factor: 0.471

4.  Succesfull multidisciplinary treatment in a case of Buerger.

Authors:  Uğur Göçen; Atakan Atalay; Lutfi Murat Deniz
Journal:  J Cardiovasc Dis Res       Date:  2013-11-09

5.  Improvement in Blood Supply After "Heparin-Dextran" Therapy in Patients of Buerger's Disease with Critical Limb Ischemia.

Authors:  Sanand Bag; Arunanshu Behera; Niranjan Khandelwal; J R Bapuraj; Rakesh Kumar Vasishta
Journal:  Indian J Surg       Date:  2012-06-19       Impact factor: 0.656

6.  Management of thromboangiitis obliterans using distraction osteogenesis: A retrospective study.

Authors:  Sunil Kulkarni; Gs Kulkarni; Ashok K Shyam; Milind Kulkarni; Ruta Kulkarni; Vidisha Kulkarni
Journal:  Indian J Orthop       Date:  2011-09       Impact factor: 1.251

7.  Thromboangiitis obliterans: Aggressive angioplasty provides a potential solution (randomized pilot study).

Authors:  Mosaad Soliman; Khaled Mowafy; N A Elsaadany; Reem Soliman; Ahmed Elmetwally
Journal:  SAGE Open Med       Date:  2020-06-04

8.  Clinical Presentation and Treatment of Thromboangiitis Obliterans With Superimposed Osteomyelitis.

Authors:  Ariel Kidron; Christian Daahir
Journal:  Cureus       Date:  2022-01-19

Review 9.  Thromboangiitis obliterans (Buerger's disease).

Authors:  Ignacio J Rivera-Chavarría; José D Brenes-Gutiérrez
Journal:  Ann Med Surg (Lond)       Date:  2016-03-29

10.  Early Results of Clinical Application of Autologous Whole Bone Marrow Stem Cell Transplantation for Critical Limb Ischemia with Buerger's Disease.

Authors:  Seon-Hee Heo; Yoong-Seok Park; Eun-Suk Kang; Kwang-Bo Park; Young-Soo Do; Kyung-Sun Kang; Dong-Ik Kim
Journal:  Sci Rep       Date:  2016-01-21       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.